Oxygen Therapy in NSTEMI Patients

Introduction to Oxygen Administration

The American Heart Association and American College of Cardiology recommend supplemental oxygen administration to NSTEMI patients only when arterial oxygen saturation is less than 90%, respiratory distress is present, or other high-risk features of hypoxemia exist 1, 2

The American College of Cardiology guidelines state that supplemental oxygen should be administered if any of the following are present: arterial oxygen saturation less than 90%, respiratory distress, cyanosis, or other high-risk features of hypoxemia 1, 2, 3
The American Heart Association recommends against routine oxygen administration in normoxic NSTEMI patients, as it may increase coronary vascular resistance, reduce coronary blood flow, and increase the risk of mortality 1, 2, 4

The DETO2X-AMI trial found that supplemental oxygen did not reduce all-cause mortality at 1 year in patients with suspected MI and oxygen saturation greater than or equal to 90% 4
The AVOID trial demonstrated that routine supplemental oxygen showed no benefit and possibly increased myocardial injury and infarct size in STEMI patients with SpO₂ greater than or equal to 94% 4

The American College of Cardiology recommends measuring oxygen saturation immediately upon patient presentation and assessing for respiratory distress or other signs of hypoxemia 1, 2
If SpO₂ is less than 90% or respiratory distress is present, administer supplemental oxygen, and titrate to maintain SpO₂ 90-96% 1, 2, 4

The American College of Cardiology recommends avoiding excessive oxygenation, as mortality appears lowest at SpO₂ 94-96% 4
In patients with chronic CO₂ retention, such as those with COPD, excessive oxygen can worsen hypercapnia, and controlled oxygen delivery should be used while monitoring both SpO₂ and CO₂ levels 5